Margaret Hoyle

587 total citations
10 papers, 116 citations indexed

About

Margaret Hoyle is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Margaret Hoyle has authored 10 papers receiving a total of 116 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Margaret Hoyle's work include Multiple Myeloma Research and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Margaret Hoyle is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Margaret Hoyle collaborates with scholars based in United States, Italy and Germany. Margaret Hoyle's co-authors include Alan Kennedy, Selim Corbacioglu, Enric Carreras, Dietger Niederwieser, Paul G. Richardson, M Sardella, Sergio Giralt, Robert J. Soiffer, Vincent T. Ho and Michelle E. Maglio and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British journal of surgery.

In The Last Decade

Margaret Hoyle

9 papers receiving 111 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret Hoyle United States 5 46 21 21 19 19 10 116
Canan Albayrak Türkiye 8 68 1.5× 11 0.5× 27 1.3× 11 0.6× 25 1.3× 21 152
Tigran Torosian Poland 7 56 1.2× 16 0.8× 9 0.4× 35 1.8× 19 1.0× 18 103
Michael Desmond Creagh United Kingdom 8 115 2.5× 19 0.9× 28 1.3× 14 0.7× 4 0.2× 10 170
Paibel Aguayo‐Hiraldo United States 8 23 0.5× 14 0.7× 8 0.4× 45 2.4× 49 2.6× 23 135
Inmaculada Farrán-Codina Spain 7 31 0.7× 14 0.7× 28 1.3× 11 0.6× 9 0.5× 10 132
Haihong Yao China 8 15 0.3× 34 1.6× 39 1.9× 20 1.1× 19 1.0× 19 128
Ally Speight United Kingdom 7 42 0.9× 35 1.7× 20 1.0× 63 3.3× 50 2.6× 14 179
Núria Padullés Zamora Spain 9 23 0.5× 14 0.7× 12 0.6× 27 1.4× 44 2.3× 29 156
Shugo Kowata Japan 7 90 2.0× 30 1.4× 39 1.9× 25 1.3× 65 3.4× 26 181
Giovanna Leone Italy 6 43 0.9× 7 0.3× 8 0.4× 25 1.3× 8 0.4× 14 106

Countries citing papers authored by Margaret Hoyle

Since Specialization
Citations

This map shows the geographic impact of Margaret Hoyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Hoyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Hoyle more than expected).

Fields of papers citing papers by Margaret Hoyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Hoyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Hoyle. The network helps show where Margaret Hoyle may publish in the future.

Co-authorship network of co-authors of Margaret Hoyle

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Hoyle. A scholar is included among the top collaborators of Margaret Hoyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Hoyle. Margaret Hoyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Suvannasankha, Attaya, Jonathan L. Kaufman, Ashraf Badros, et al.. (2025). Safety and efficacy of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma: Results from the phase 1b MagnetisMM-30 trial. Blood. 146(Supplement 1). 100–100.
2.
Schuster, Steven R., et al.. (2024). Evaluation of elranatamab vs EPd, PVd, or Kd in patients with relapsed or refractory multiple myeloma and prior anti-CD38–directed therapy: MagnetisMM-32.. Journal of Clinical Oncology. 42(16_suppl). TPS7576–TPS7576. 1 indexed citations
3.
4.
5.
Hyman, David M., Amelia Zelnak, Todd M. Bauer, et al.. (2019). JAVELIN BRCA/ATM: A phase 2 trial of avelumab (anti–PD-L1) plus talazoparib (PARP inhibitor) in patients with advanced solid tumors with a BRCA1/2 or ATM defect.. Journal of Clinical Oncology. 37(15_suppl). TPS2660–TPS2660. 11 indexed citations
6.
Lalwani, Sanjay, Sharad Agarkhedkar, Nithya Gogtay, et al.. (2015). Safety and immunogenicity of an investigational meningococcal ACWY conjugate vaccine (MenACWY-CRM) in healthy Indian subjects aged 2 to 75 years. International Journal of Infectious Diseases. 38. 36–42. 14 indexed citations
7.
Richardson, Paul G., Selim Corbacioglu, Vincent T. Ho, et al.. (2012). Drug safety evaluation of defibrotide. Expert Opinion on Drug Safety. 12(1). 123–136. 59 indexed citations
8.
Corbacioglu, Selim, Enric Carreras, Dietger Niederwieser, et al.. (2010). Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients (Pts).. Blood. 116(21). 3482–3482. 4 indexed citations
9.
10.
Hoyle, Margaret, et al.. (1977). Small bowel ischaemia and infarction in young women taking oral contraceptives and progestational agents. British journal of surgery. 64(8). 533–537. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Canan Albayrak Breakdown of academic impact, for papers by Tigran Torosian Breakdown of academic impact, for papers by Michael Desmond Creagh Breakdown of academic impact, for papers by Paibel Aguayo‐Hiraldo Breakdown of academic impact, for papers by Inmaculada Farrán-Codina Breakdown of academic impact, for papers by Haihong Yao Breakdown of academic impact, for papers by Ally Speight Breakdown of academic impact, for papers by Núria Padullés Zamora Breakdown of academic impact, for papers by Shugo Kowata Breakdown of academic impact, for papers by Giovanna Leone
Rankless by CCL
2026